BACKGROUND: GH deficiency (GHD) is often associated with cardiovascular risk factors, including abdominal fat accumulation, hypercholesterolemia, and increased C-reactive protein. Despite the presence of these risk factors, adults with congenital lifetime isolated GHD (IGHD) due to an inactivating mutation in the GHRH receptor gene do not have premature atherosclerosis. OBJECTIVE: The aim was to study the serum levels of adiponectin and leptin (antiatherogenic and atherogenic adipokine, respectively), and the urinary albumin excretion (UAE) in these IGHD individuals. DESIGN AND PATIENTS: We conducted a cross-sectional study of 20 IGHD individuals (seven males; age, 50.8 +/- 14.6 yr) and 22 control subjects (eight males; age, 49.9 +/- 11.5 yr). MAIN OUTCOME MEASURES: Anthropometric factors, body composition, blood pressure, serum adiponectin, leptin, and UAE were measured. RESULTS: Adiponectin was higher [12.8 (7.1) vs. 9.7 (5) ng/ml; P = 0.041] in IGHD subjects, whereas no difference was observed in leptin [7.3 (6.3) vs. 9.3 (18.7 ng/ml] and UAE [8.6 (13.8) vs. 8.5 (11.1) microg/min]. CONCLUSIONS: Subjects with lifetime untreated IGHD have an adipokine profile with high adiponectin and normal leptin levels that may delay vascular damage and lesions of the renal endothelium.
BACKGROUND:GH deficiency (GHD) is often associated with cardiovascular risk factors, including abdominal fat accumulation, hypercholesterolemia, and increased C-reactive protein. Despite the presence of these risk factors, adults with congenital lifetime isolated GHD (IGHD) due to an inactivating mutation in the GHRH receptor gene do not have premature atherosclerosis. OBJECTIVE: The aim was to study the serum levels of adiponectin and leptin (antiatherogenic and atherogenic adipokine, respectively), and the urinary albumin excretion (UAE) in these IGHD individuals. DESIGN AND PATIENTS: We conducted a cross-sectional study of 20 IGHD individuals (seven males; age, 50.8 +/- 14.6 yr) and 22 control subjects (eight males; age, 49.9 +/- 11.5 yr). MAIN OUTCOME MEASURES: Anthropometric factors, body composition, blood pressure, serum adiponectin, leptin, and UAE were measured. RESULTS:Adiponectin was higher [12.8 (7.1) vs. 9.7 (5) ng/ml; P = 0.041] in IGHD subjects, whereas no difference was observed in leptin [7.3 (6.3) vs. 9.3 (18.7 ng/ml] and UAE [8.6 (13.8) vs. 8.5 (11.1) microg/min]. CONCLUSIONS: Subjects with lifetime untreated IGHD have an adipokine profile with high adiponectin and normal leptin levels that may delay vascular damage and lesions of the renal endothelium.
Authors: Joselina L M Oliveira; Manuel H Aguiar-Oliveira; Argemiro D'Oliveira; Rossana M C Pereira; Carla R P Oliveira; Catarine T Farias; José A Barreto-Filho; Fernando D Anjos-Andrade; Celi Marques-Santos; Adão C Nascimento-Junior; Erica O Alves; Francielle T Oliveira; Viviane C Campos; Roberto Ximenes; Amanda Blackford; Giovanni Parmigiani; Roberto Salvatori Journal: J Clin Endocrinol Metab Date: 2007-10-02 Impact factor: 5.958
Authors: M Russell; M Bredella; P Tsai; N Mendes; K K Miller; A Klibanski; M Misra Journal: J Clin Endocrinol Metab Date: 2009-05-12 Impact factor: 5.958
Authors: A E Stevenson; B A J Evans; E F Gevers; C Elford; R W J McLeod; M J Perry; M M El-Kasti; K T Coschigano; J J Kopchick; S L Evans; T Wells Journal: Am J Physiol Endocrinol Metab Date: 2008-11-11 Impact factor: 4.310
Authors: Jaime Guevara-Aguirre; Arlan L Rosenbloom; Priya Balasubramanian; Enrique Teran; Marco Guevara-Aguirre; Carolina Guevara; Patricio Procel; Irene Alfaras; Rafael De Cabo; Stefano Di Biase; Luis Narvaez; Jannette Saavedra; Valter D Longo Journal: J Clin Endocrinol Metab Date: 2015-05-18 Impact factor: 5.958
Authors: Miburge B Gois; Roberto Salvatori; Manuel H Aguiar-Oliveira; Francisco A Pereira; Carla R P Oliveira; Luiz A Oliveira-Neto; Rossana M C Pereira; Anita H O Souza; Enaldo V Melo; Francisco J A de Paula Journal: Clin Endocrinol (Oxf) Date: 2012-09 Impact factor: 3.478
Authors: Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick Journal: Growth Horm IGF Res Date: 2011-04-05 Impact factor: 2.372
Authors: Menilson Menezes; Roberto Salvatori; Luiza D Melo; Ívina E S Rocha; Carla R P Oliveira; Rossana M C Pereira; Anita H O Souza; Eugênia H O Valença; Enaldo V Melo; Viviane C Campos; Flavia O Costa; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2013-02-10 Impact factor: 3.633
Authors: Cindi G Marinho; Hyder A Melo; Roberto Salvatori; Marco A P Nunes; Carla R P Oliveira; Viviane C Campos; Cynthia S Barros-Oliveira; Alécia A Oliveira-Santos; Nelmo V Menezes; Hertz T Santos-Júnior; Elenilde G Santos; Manuela A Melo; Joselina L M Oliveira; Enaldo V Melo; Manuel H Aguiar-Oliveira Journal: Endocrine Date: 2020-07-12 Impact factor: 3.633